| 1994 Consensus conference on acute GVHD grading. D Przepiorka, D Weisdorf, P Martin, HG Klingemann, P Beatty, J Hows, ... Bone marrow transplantation 15 (6), 825-828, 1995 | 5480 | 1995 |
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report AH Filipovich, D Weisdorf, S Pavletic, G Socie, JR Wingard, SJ Lee, ... Biology of blood and marrow transplantation 11 (12), 945-956, 2005 | 4099 | 2005 |
| Acute myeloid leukemia H Döhner, DJ Weisdorf, CD Bloomfield New England Journal of Medicine 373 (12), 1136-1152, 2015 | 3457 | 2015 |
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working … MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ... Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015 | 2453 | 2015 |
| Origins of circulating endothelial cells and endothelial outgrowth from blood Y Lin, DJ Weisdorf, A Solovey, RP Hebbel The Journal of clinical investigation 105 (1), 71-77, 2000 | 2093 | 2000 |
| Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer JS Miller, Y Soignier, A Panoskaltsis-Mortari, SA McNearney, GH Yun, ... Blood 105 (8), 3051-3057, 2005 | 2002 | 2005 |
| High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation SJ Lee, J Klein, M Haagenson, LA Baxter-Lowe, DL Confer, M Eapen, ... Blood, The Journal of the American Society of Hematology 110 (13), 4576-4583, 2007 | 1531 | 2007 |
| A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation JL Goodman, DJ Winston, RA Greenfield, PH Chandrasekar, B Fox, ... New England Journal of Medicine 326 (13), 845-851, 1992 | 1414 | 1992 |
| Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment … JE Wagner, JN Barker, TE DeFor, KS Baker, BR Blazar, C Eide, ... Blood, The Journal of the American Society of Hematology 100 (5), 1611-1618, 2002 | 1350 | 2002 |
| Lenalidomide after stem-cell transplantation for multiple myeloma PL McCarthy, K Owzar, CC Hofmeister, DD Hurd, H Hassoun, ... New England Journal of Medicine 366 (19), 1770-1781, 2012 | 1323 | 2012 |
| Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy JN Barker, DJ Weisdorf, TE DeFor, BR Blazar, PB McGlave, JS Miller, ... Blood 105 (3), 1343-1347, 2005 | 1113 | 2005 |
| Palifermin for oral mucositis after intensive therapy for hematologic cancers R Spielberger, P Stiff, W Bensinger, T Gentile, D Weisdorf, T Kewalramani, ... New England Journal of Medicine 351 (25), 2590-2598, 2004 | 1103 | 2004 |
| Peripheral-blood stem cells versus bone marrow from unrelated donors C Anasetti, BR Logan, SJ Lee, EK Waller, DJ Weisdorf, JR Wingard, ... New England Journal of Medicine 367 (16), 1487-1496, 2012 | 994 | 2012 |
| Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse … N Flomenberg, LA Baxter-Lowe, D Confer, M Fernandez-Vina, ... Blood 104 (7), 1923-1930, 2004 | 923 | 2004 |
| Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age C Kollman, CWS Howe, C Anasetti, JH Antin, SM Davies, AH Filipovich, ... Blood, The Journal of the American Society of Hematology 98 (7), 2043-2051, 2001 | 862 | 2001 |
| Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation P Armand, HT Kim, BR Logan, Z Wang, EP Alyea, ME Kalaycio, ... Blood, The Journal of the American Society of Hematology 123 (23), 3664-3671, 2014 | 839 | 2014 |
| A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved … CS Cutler, SJ Lee, P Greenberg, HJ Deeg, WS Pérez, C Anasetti, ... Blood 104 (2), 579-585, 2004 | 823 | 2004 |
| Long-term survival and late deaths after allogeneic bone marrow transplantation G Socié, JV Stone, JR Wingard, D Weisdorf, PJ Henslee-Downey, ... New England Journal of Medicine 341 (1), 14-21, 1999 | 802 | 1999 |
| Risk factors for acute GVHD and survival after hematopoietic cell transplantation M Jagasia, M Arora, MED Flowers, NJ Chao, PL McCarthy, CS Cutler, ... Blood, The Journal of the American Society of Hematology 119 (1), 296-307, 2012 | 790 | 2012 |
| Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study RE Curtis, LB Travis, PA Rowlings, G Socié, DW Kingma, PM Banks, ... Blood, The Journal of the American Society of Hematology 94 (7), 2208-2216, 1999 | 788 | 1999 |
